Oxcarbazepine Tablet, Extended Release
Product Images NDC 60505-4130

This is a description for Oxcarbazepine Extended-Release Tablets containing 150 mg per tablet. It is recommended to store between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). The tablets should be kept away from light and moisture, dispensed in a tight, light-resistant container. Dosage instructions are included in the package insert recommending once-daily consumption by swallowing the tablet whole without cutting, crushing, or chewing. The tablets are to be kept out of reach of children. Pharmacies should dispense these tablets along with a Medication Guide that is available online for patients. The manufacturer is Apotex Inc, based in Toronto, Ontario, Canada, and the tablets are distributed by Apotex Corp in Weston, Florida 33326.*

Each extended-release tablet contains 300 mg of oxcarbazepine, USP. It should be stored at 20°C to 25°C (68°F to 77°F) with excursions permitted from 15°C to 30°C (59°F to 86°F). The tablets should be protected from light and moisture and dispensed in a tight, light-resistant container. The medication is intended for once daily consumption and should be swallowed whole; it should not be cut, crushed, or chewed. Pharmacists are advised to dispense with a Medication Guide available at the provided link to each patient. The product is from Apotex Corp and is manufactured in Canada.*

This is a description of Oxcarbazepine Extended-Release Tablets containing 600 mg of the active ingredient. The tablets are designed for once-daily dosing and should be swallowed whole without cutting, crushing, or chewing. It is important to store the tablets at a controlled room temperature, protect them from light and moisture, and keep them out of reach of children. Dispense in a tight, light-resistant container. The medication guide should be provided to each patient.*